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To conﬁ   rm the presence of Crimean-Congo hemor-
rhagic fever in Sudan, we tested serum of 8 patients with 
hemorrhagic fever in a rural hospital in 2008. Reverse tran-
scription–PCR identiﬁ  ed Crimean-Congo hemorrhagic fever 
virus. Its identiﬁ  cation as group III lineage indicated links to 
virus strains from South Africa, Mauritania, and Nigeria.
C
rimean-Congo hemorrhagic fever virus (CCHFV; fam-
ily Bunyaviridae, genus Nairovirus) is a tick-borne vi-
rus. Its tripartite RNA genome consists of small (S), medi-
um, and large segments. The virus is distributed throughout 
much of Africa, Asia, and southern Europe (1–5). In some 
regions, the virus is responsible for annual outbreaks of 
hemorrhagic fever with high case-fatality rates; in others, it 
causes sporadic cases only. Because of its association with 
rapid-onset hemorrhagic fever and an ≈30% case-fatality 
rate, CCHFV is on the US Select Agent list of agents con-
sidered to have bioterrorism potential (2–5).
Distribution of CCHF largely mirrors that of its Ixo-
did tick hosts, particularly those of the genus Hyalom-
ma (1). Persons become infected when bitten by virus-
infected ticks or after contact with blood or tissue from 
viremic livestock or other persons. Outbreaks often in-
volve persons in rural communities, such as shepherds, 
slaughterhouse workers, or medical staff of resource-poor 
hospitals. Despite presence of Hyalomma tick vectors in 
Sudan, no CCHF cases have been conﬁ  rmed there. How-
ever, in the past 2 years, suspected CCHF outbreaks and 
sporadic cases in the Kordufan region of Sudan have been 
reported.
From a public health perspective, conﬁ  rming CCHF in 
Sudan and determining which virus lineages may be pres-
ent in this region will provide a more detailed understand-
ing of the movement of virus strains and identiﬁ  cation of 
areas at risk for CCHFV. We therefore analyzed an out-
break of hemorrhagic fever, including a nosocomial chain 
of transmission in a rural hospital in Sudan in 2008.
The Study
In October 2008, an outbreak of hemorrhagic fever 
was reported in Al-fulah, Kordufan, Sudan. The index pa-
tient was a 60-year-old man who had worked as a butcher. 
The source of his infection was suspected to have been tis-
sues and blood of an infected animal, although follow-up 
investigation was unable to precisely determine the source. 
He was admitted to a rural hospital with an acute febrile 
hemorrhagic illness after 3 days of high fever, chills, and 
headache. He had taken antimalarial medication at home, 
but his condition did not improve. He had epistaxis, black 
bloody vomitus, and diarrhea on the last 2 days of his ill-
ness. He died on day 5 after onset of illness.
No protective gloves or antiseptic products were avail-
able at the hospital. Illness developed in a male nurse who 
had provided care to the index patient 6 days after the index 
patient had been admitted to the hospital and in the chief 
male nurse a few days after that. The index patient’s sis-
ter was also considered to have a suspected case; she had 
sought care at the hospital after a heavy menstrual period 
that progressed to massive vaginal bleeding. The midwife 
who performed the gynecologic examination later became 
ill with high fever, vomiting of blood, and bloody diarrhea. 
As is tradition and social obligation in rural hospitals in this 
region, 2 relatives of the index patient had alternated caring 
for him (e.g., dressing him, changing his mattresses and 
bed sheets, nursing, and sleeping beside him) while he was 
in the hospital, and both acquired the infection (rapid onset 
of fever, headache, nausea, vomiting of blood, and bloody 
diarrhea). No details were available for 3 other patients 
with hemorrhagic fever associated with the hospital. 
Of these 10 patients, 9 were admitted to a rural hospital 
in Al-fulah, where 6 continued to bleed, subsequently be-
came comatose, and died. Records were unavailable for the 
other 3. In addition, 3 probable cases in the community were 
reported. Each of these 3 persons had a course of hemor-
rhagic disease and death that was compatible with CCHF; 
they had not been admitted to the hospital and could not be 
traced because of poor security conditions in the region. 
Patient ages varied from 15 to 70 years. Nosocomial trans-
mission of the virus was likely the result of lack of personal 
protection for the hospital staff and the attending relatives, 
as has been often noted during previous outbreaks (6).
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able, 8 had evidence of acute CCHFV infection. Direct im-
munoﬂ  uorescence assay detected no antibodies to CCHFV 
in any of the serum samples; however, all samples had been 
collected on days 1–3 of illness. Virus RNA extracted from 
each of the samples by QIAamp (QIAGEN GmbH, Hilden, 
Germany) was positive according to reverse transcription–
PCR (RT-PCR) speciﬁ  c for CCHFV (7). The RNA was 
then used in RT-PCRs to amplify the entire virus S segment 
for complete sequencing as described (8). The full-length S 
segment nucleotide sequence of the strains from Sudan was 
1,673 nt long, and the 8 viral sequences were identical with 
the exception of that from patient 4 (GenBank accession 
nos. GQ862371–2). A maximum-likelihood phylogenetic 
analysis of the S segment sequences placed the viruses from 
Sudan in group III (8), which is composed exclusively of 
viruses of African origin, including South Africa, Maurita-
nia, and Nigeria (Figure). The highest nucleotide sequence 
identity was seen with strains from South Africa.
Conclusions
Laboratory conﬁ  rmation of 8 cases of CCHF dem-
onstrates the presence of this disease in Sudan. Genetic 
analysis of the viruses showed that the strain involved was 
similar to strains found in South Africa, Mauritania, and 
Nigeria.
Detailed analysis of virus outbreaks is often limited by 
the lack of appropriate high-containment facilities required 
for virus isolation. However, appropriately sampled and 
stored acute-phase serum samples can have high titers of 
the virus, which enable extraction of virus RNA and ge-
nome sequencing studies without prior ampliﬁ  cation of the 
virus in cell culture. In this study, serum specimens from 8 
patients who died were positive for CCHFV by RT-PCR. 
Lack of virus-speciﬁ  c antibodies 1–3 days after onset of 
illness can be explained by the severity and rapid course 
of the disease, which does not allow sufﬁ  cient time for an-
tibody production. Virus-speciﬁ  c antibodies are, however, 
generally seen later in the course of illness and in persons 
who survive the infection.
Antibody studies have suggested the presence of vari-
ous arboviruses in Sudan (10,11). Indirect evidence for 
CCHFV in animals in Sudan came from ﬁ  nding CCHFV-
speciﬁ  c antibodies in animals imported from Sudan: camels 
in Egypt (12) and sheep and goats in Saudi Arabia (13). The 
ﬁ  nding that the Al-fulah outbreak was caused by a CCHFV 
strain from genetic group III illustrates how different virus 
strains and lineages can move with livestock transport or 
possibly bird migrations. The genome plasticity of the vi-
rus is surprisingly high for an arthropod-borne virus. This 
genetic diversity appears to be the result of not only accu-
mulation of mutations but also of frequent RNA segment 
reassortment and even RNA recombination (8,14,15).
Clearly, this CCHFV is present in Sudan, and physi-
cians should consider CCHF as a diagnosis for hemorrhagic 
fever cases in the region. In addition, efforts to provide ap-
propriate personal protective supplies and training to medi-
cal staff in rural areas should be increased to help minimize 
risk for caregivers.
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Figure. Phylogenetic relationship of Crimean-Congo hemorrhagic 
fever virus (CCHFV) full-length small (S) segments. Phylogenetic 
analysis used 47 full-length CCHFV S segments available in 
GenBank. GARLI (v0.96b8) (9) with default settings was used to 
generate a maximum-likelihood tree with bootstrap support values 
from 1,000 replicates. From the analysis, a 50% majority-rule tree 
was constructed. Virus strains from Sudan patients 1, 2, 3, 6, 7, 8, 
and 9 (GenBank accession no. GQ862371) were identical, and the 
virus sequence from patient 4 (GenBank accession no. GQ862372) 
differed by 1 nt. Each strain is listed by its location, strain name, and 
year of isolation, when available. Boldface indicates strains from 
Sudan; braces indicate previously described genetic lineages (8).Nosocomial Outbreak of CCHF, Sudan
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etymologia etymologia
Tropheryma whipplei
[tro-fer’ĭ-mə wi’-pəl-ē-ī]
The genus name of this gram-positive, rod-shaped, soil-dwelling bacterium was taken from Greek trophe 
(nourishment) and eryma (barrier) because malabsorption was a feature of the infection it caused. The species 
name honors George Hoyt Whipple (1878–1976), an American pathologist and medical educator, who, in 1907, 
ﬁ  rst described the clinical syndrome later known as Whipple’s disease. In 1991, when sections of the genome 
were sequenced, the organism was named T. whippelii; the spelling was corrected in 2001.
Source:  La Scola B, Fenollar F, Fournier P-E, Altwegg M, Mallet M-N, Raoult D. Description of Tropheryma whipplei gen. nov., 
sp. nov, the Whipple’s disease bacillus. Int J Syst Evol Microbiol. 2001;51:1471–9. 
Bousbia S, Papazian L, Auffray J-P, Fenollar F, Martin C, Li W, et al. Tropheryma whipplei in patients with pneumonia. Emerg 
Infect Dis. 2010;16:258–63.
 